This report from GlobalData will help you better understand the potential impact of Trump 2.0 on the Automotive industry.

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Slowing electric-vehicle adoption is likely to accelerate even further as President-elect Donald Trump delivers on his ...

Previous United Nations COP (Conference of the Parties) events indicate that they are increasingly less impactful, but that enterprise communications service providers should continue to lead the way ...

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including ...

Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease ...

With Donald Trump securing his return to the White House for a second term, we explore what his second term could mean for ...

The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...

A previous version of this article incorrectly said that U.S. restaurant spending is expected to reach $1.22 billion in 2024, ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist. These tests raise concerns ...

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.